peptibase
Hormonal

Teriparatide

Also known as: Forteo, PTH 1-34

FDA Approved
Share:

Key Facts: Teriparatide

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Osteoporosis
Administration
Subcutaneous injection daily
Typical Dose
20 mcg daily
Frequency
Once daily
Duration
Maximum 2 years (lifetime limit due to osteosarcoma concern)
Also Known As
Forteo, PTH 1-34

Mechanism of Action

Teriparatide contains amino acids 1-34 of PTH. Intermittent dosing stimulates osteoblasts more than osteoclasts, resulting in net bone formation. This anabolic effect differs from antiresorptive osteoporosis drugs.

Research Summary

Fracture Prevention Trial showed 65% reduction in vertebral fractures. Only bone-building (anabolic) therapy available until abaloparatide. Increases bone mineral density more effectively than bisphosphonates initially.

Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosingⓘ

Community experience

Common Dose

20 mcg daily

Range

20 mcg daily

Frequency

Once daily

FDA-approved PTH analog for osteoporosis. Max 2 years treatment. Injection in thigh or abdomen.

Research Dosingⓘ

Scientific studies

FDA-approved dosing

Doses from Studies

Duration

Maximum 2 years (lifetime limit due to osteosarcoma concern)

Administration

Subcutaneous injection daily

Timing & Administration

Best Time to Take

Morning or as directed

Follow recommended protocol

Food Recommendation

With or without food

Why This Timing?

Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • ●Joint pain (10%)
  • ●Nausea
  • ●Headache
  • ●Dizziness
  • ●Leg cramps
  • ●Injection site reactions
  • ●Orthostatic hypotension
  • ●Hypercalcemia
  • ●BOXED WARNING: Osteosarcoma risk - limit to 2 years
  • ●FDA approved (Forteo)

References

Research This Peptide Further

PubMedClinicalTrials.govFDA.gov

Frequently Asked Questions

What does Teriparatide do?

A recombinant fragment of parathyroid hormone that stimulates bone formation. FDA approved for osteoporosis with high fracture risk.

How does Teriparatide work?

Teriparatide contains amino acids 1-34 of PTH. Intermittent dosing stimulates osteoblasts more than osteoclasts, resulting in net bone formation. This anabolic effect differs from antiresorptive osteoporosis drugs.

Is Teriparatide FDA approved?

Yes, Teriparatide is FDA approved. FDA Approved - Osteoporosis

What are the side effects of Teriparatide?

Reported side effects include: Joint pain (10%), Nausea, Headache, Dizziness, Leg cramps. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of Teriparatide?

Community-reported common dose: 20 mcg daily (Once daily). Range: 20 mcg daily. Administration: Subcutaneous injection daily. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with Teriparatide or used in similar applications.

Oxytocin

FDA

A naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.

Hormonal

Gonadorelin

FDA

A synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.

Hormonal

Leuprolide

FDA

A GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Hormonal

Desmopressin

FDA

A synthetic analog of vasopressin (ADH) used for diabetes insipidus, bedwetting, and bleeding disorders. Does not cause vasoconstriction like natural vasopressin.

Hormonal

Octreotide

FDA

A synthetic somatostatin analog that inhibits multiple hormones. Used for acromegaly, carcinoid tumors, and various GI conditions.

Hormonal

Lanreotide

FDA

A long-acting somatostatin analog similar to octreotide. FDA approved for acromegaly and gastroenteropancreatic neuroendocrine tumors.

Hormonal
How to Use TeriparatideTeriparatide AlternativesCompare with SimilarBrowse All Peptides

Want updates on Teriparatide research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Back to all peptides